7
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Adenosine A 2A and A 3 Receptors Are Able to Interact with Each Other. A Further Piece in the Puzzle of Adenosine Receptor-Mediated Signaling

      research-article

      Read this article at

      ScienceOpenPublisherPMC
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The aim of this paper was to check the possible interaction of two of the four purinergic P1 receptors, the A 2A and the A 3. Discovery of the A 2A–A 3 receptor complex was achieved by means of immunocytochemistry and of bioluminescence resonance energy transfer. The functional properties and heteromer print identification were addressed by combining binding and signaling assays. The physiological role of the novel heteromer is to provide a differential signaling depending on the pre-coupling to signal transduction components and/or on the concentration of the endogenous agonist. The main feature was that the heteromeric context led to a marked decrease of the signaling originating at A 3 receptors. Interestingly from a therapeutic point of view, A 2A receptor antagonists overrode the blockade, thus allowing A 3 receptor-mediated signaling. The A 2A–A 3 receptor heteromer print was detected in primary cortical neurons. These and previous results suggest that all four adenosine receptors may interact with each other. Therefore, each adenosine receptor could form heteromers with distinct properties, expanding the signaling outputs derived from the binding of adenosine to its cognate receptors.

          Related collections

          Most cited references39

          • Record: found
          • Abstract: found
          • Article: not found

          Presynaptic control of striatal glutamatergic neurotransmission by adenosine A1-A2A receptor heteromers.

          The functional role of heteromers of G-protein-coupled receptors is a matter of debate. In the present study, we demonstrate that heteromerization of adenosine A1 receptors (A1Rs) and A2A receptors (A2ARs) allows adenosine to exert a fine-tuning modulation of glutamatergic neurotransmission. By means of coimmunoprecipitation, bioluminescence and time-resolved fluorescence resonance energy transfer techniques, we showed the existence of A1R-A2AR heteromers in the cell surface of cotransfected cells. Immunogold detection and coimmunoprecipitation experiments indicated that A1R and A2AR are colocalized in the same striatal glutamatergic nerve terminals. Radioligand-binding experiments in cotransfected cells and rat striatum showed that a main biochemical characteristic of the A1R-A2AR heteromer is the ability of A2AR activation to reduce the affinity of the A1R for agonists. This provides a switch mechanism by which low and high concentrations of adenosine inhibit and stimulate, respectively, glutamate release. Furthermore, it is also shown that A1R-A2AR heteromers constitute a unique target for caffeine and that chronic caffeine treatment leads to modifications in the function of the A1R-A2AR heteromer that could underlie the strong tolerance to the psychomotor effects of caffeine.
            • Record: found
            • Abstract: found
            • Article: not found

            G-protein-coupled receptor heterodimerization modulates receptor function.

            The opioid system modulates several physiological processes, including analgesia, the stress response, the immune response and neuroendocrine function. Pharmacological and molecular cloning studies have identified three opioid-receptor types, delta, kappa and mu, that mediate these diverse effects. Little is known about the ability of the receptors to interact to form new functional structures, the simplest of which would be a dimer. Structural and biochemical studies show that other G-protein-coupled receptors (GPCRs) interact to form homodimers. Moreover, two non-functional receptors heterodimerize to form a functional receptor, suggesting that dimerization is crucial for receptor function. However, heterodimerization between two fully functional receptors has not been documented. Here we provide biochemical and pharmacological evidence for the heterodimerization of two fully functional opioid receptors, kappa and delta. This results in a new receptor that exhibits ligand binding and functional properties that are distinct from those of either receptor. Furthermore, the kappa-delta heterodimer synergistically binds highly selective agonists and potentiates signal transduction. Thus, heterodimerization of these GPCRs represents a novel mechanism that modulates their function.
              • Record: found
              • Abstract: found
              • Article: not found

              D1-D2 dopamine receptor heterooligomers with unique pharmacology are coupled to rapid activation of Gq/11 in the striatum.

              We demonstrate a heteromeric D1-D2 dopamine receptor signaling complex in brain that is coupled to Gq/11 and requires agonist binding to both receptors for G protein activation and intracellular calcium release. The D1 agonist SKF83959 was identified as a specific agonist for the heteromer that activated Gq/11 by functioning as a full agonist for the D1 receptor and a high-affinity partial agonist for a pertussis toxin-resistant D2 receptor within the complex. We provide evidence that the D1-D2 signaling complex can be more readily detected in mice that are 8 months in age compared with animals that are 3 months old, suggesting that calcium signaling through the D1-D2 dopamine receptor complex is relevant for function in the postadolescent brain. Activation of Gq/11 through the heteromer increases levels of calcium/calmodulin-dependent protein kinase IIalpha in the nucleus accumbens, unlike activation of Gs/olf-coupled D1 receptors, indicating a mechanism by which D1-D2 dopamine receptor complexes may contribute to synaptic plasticity.

                Author and article information

                Journal
                Int J Mol Sci
                Int J Mol Sci
                ijms
                International Journal of Molecular Sciences
                MDPI
                1422-0067
                17 July 2020
                July 2020
                : 21
                : 14
                : 5070
                Affiliations
                [1 ]Department of Biochemistry and Physiology, Faculty of Pharmacy and Food Science, University of Barcelona, 08028 Barcelona, Spain; alilloma55@ 123456gmail.com (A.L.); ire-reyes@ 123456hotmail.com (I.R.-R.); g.navarro@ 123456ub.edu (G.N.)
                [2 ]Department of Morphology and Cell Biology, Faculty of Medicine, University of Oviedo, 33006 Asturias, Spain; martinezpinillaeva@ 123456gmail.com
                [3 ]Instituto de Neurociencias del Principado de Asturias (INEUROPA), 33006 Asturias, Spain
                [4 ]Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), 33006 Asturias, Spain
                [5 ]Centro de Investigación Biomédica en Red Enfermedades Neurodegenerativas (CIBERNED), 28031 Madrid, Spain
                [6 ]Molecular Neurobiology Laboratory, Department of Biochemistry and Molecular Biomedicine, University of Barcelona, 08028 Barcelona, Spain
                [7 ]School of Chemistry, Universitat de Barcelona, Diagonal 645, 08028 Barcelona, Spain
                Author notes
                [* ]Correspondence: rfranco123@ 123456gmail.com or rfranco@ 123456ub.edu ; Tel.: +34-934021208
                [†]

                Current address: RG Neuroplasticity, Leibniz Institute for Neurobiology, 39118, Magdeburg, Germany.

                [‡]

                Equal contribution.

                Author information
                https://orcid.org/0000-0002-0572-0926
                https://orcid.org/0000-0003-4654-0873
                https://orcid.org/0000-0003-2549-4919
                Article
                ijms-21-05070
                10.3390/ijms21145070
                7404137
                32709103
                e2c0dfcc-eae7-4368-9659-4add8202cb89
                © 2020 by the authors.

                Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ( http://creativecommons.org/licenses/by/4.0/).

                History
                : 25 June 2020
                : 13 July 2020
                Categories
                Article

                Molecular biology
                cross-antagonism,cortical neurons,heteromer print,purinergic p1 receptors,g-protein-coupled receptors

                Comments

                Comment on this article

                Related Documents Log